Malcolm joined Arlington in 2014 and is responsible for investing in the healthcare sector. Prior to joining Arlington, Malcolm was a Vice President at Avista Capital Partners where he focused primarily on investments in the healthcare industry. Prior to Avista, Malcolm was an Associate at Oak Hill Capital Partners where he was responsible for investments in the firm’s Business and Financial Services industry group. Malcolm also worked at Bear, Stearns & Co. in its Leveraged Finance group.
Malcolm earned an M.B.A. degree from Harvard Business School and holds a B.S. degree, with distinction, from the University of Virginia.
Malcolm currently serves on the Board of Directors of Everest Clinical Research, Grand River Aseptic Manufacturing, and Molecular Products. Malcolm has previously been a member of the Board of Directors of Avalign Technologies, MicroPact, and Ontario Systems.